Preparation and Evaluation of Nanoemulsion-based Aerosol Formulation for the Pulmonary Delivery of Azithromycin
Abstract
Abstract Views: 0
Azithromycin (AZM) is an effective macrolide antibiotic against pathogenic microorganisms causing respiratory tract infections. AZM is not only effective in the exacerbations of Chronic Obstructive Pulmonary Disease (COPD) caused by bacteria but has also shown antiviral effects on SARS-CoV-2, making it an ideal candidate to empirically treat the coronavirus disease. The drug is a lipophilic molecule which belongs to BCS class II with a relatively low oral bioavailability of 37%. This brings forth the need to formulate a novel drug delivery system to directly target the respiratory tract by aerosolization. The aerosolization of AZM improves its antibacterial efficacy, lowers the dose, and avoids systemic side effects. These traits reduce the likelihood of antibiotic resistance. Three nanoemulsions (NEs) of AZM were made using eucalyptus, lavender, and peppermint oil as solvents, distilled water as aqueous phase, and Tween 20 as surfactant. All the formulations were made using a similar technique, that is, shake flask method. The characterization of all formulations was performed including visual inspection, number of flask inversions, percent transmittance, emulsification efficiency, thermodynamic stability (heating-cooling cycle, centrifugation, freeze-thaw cycle, cloud point measurement), pH, refractive index, viscosity, droplet size analysis and PDI, spray efficiency, and spray acuity/capacity. Then, the NE formulations were aerosolized. These aerosolized NEs of AZM can help to deliver the drug directly to the infected lung cells. The therapeutic effect can be achieved rapidly at a relatively low dose using an aerosol formulation. This study suggests that optimized aerosolization of NEs can be used to effectively deliver AZM to the respiratory tract.
Downloads
References
Firth A, Prathapan P. Azithromycin: the first broad-spectrum Therapeutic. Eur J Med Chem. 2020;207:e112739. https://doi.org/10.1016/j.ejmech.2020.112739
Ballow CH, Amsden GW. Azithromycin: the first azalide antibiotic. Ann Pharm. 1992;26(10):1253–1261. https://doi.org/10.1177/106002809202601014
Idkaidek NM, Najib N, Salem I, Jilani J. Physiologically-based IVIVC of azithromycin. Am J Pharmacol Sci. 2014;2(6):100–102. https://doi.org/10.12691/ajps-2-6-1
Metlay JP, Waterer GW. Treatment of community-acquired pneumonia during the coronavirus disease 2019 (COVID-19) pandemic. Ann Intern Med. 2020;173(4):304–305. https://doi.org/10.7326/M20-2189
Naseri N, Zakeri-Milani P, Hamishehkar H, Pilehvar-Soltanahmadi Y, Valizadeh H. Development, in vitro characterization, antitumor and aerosol performance evaluation of respirable prepared by self-nanoemulsification method. Drug Res. 2017;67(06):343–348. https://doi.org/10.1055/s-0043-102404
Arora SC, Sharma PK, Irchhaiya R, Khatkar A, Singh N, Gagoria J. Development, characterization and solubility study of solid dispersions of azithromycin dihydrate by solvent evaporation method. J Adv Pharm Technol Res. 2010;1(2):221–228.
Stielow M, Witczyńska A, Kubryń N, Fijałkowski Ł, Nowaczyk J, Nowaczyk A. The bioavailability of drugs—the current state of knowledge. Molecules.2023;28(24):e8038. https://doi.org/10.3390/molecules28248038
Ghosh S, Ghosh S, Sil PC. Role of nanostructures in improvising oral medicine. Toxicol Rep. 2019;6:358–368. https://doi.org/10.1016/j.toxrep.2019.04.004
Thorat YS, Gonjari ID, Hosmani AH. Solubility enhancement techniques: a review on conventional and novel approaches. Int J Pharm Sci Res. 2011;2(10):2501–2513.
Ahmad N, Ansari K, Alamoudi MK, et al. A novel mucoadhesive paliperidone-nanoemulsion developed using the ultrasonication method in the treatment of schizophrenia. RCS Adv. 2024;14(33):23952–23972. https://doi.org/10.1039/D4RA04624B
Amani A, York P, Chrystyn H, Clark BJ. Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizers. AAPS PharmSciTech. 2010;11:1147–1151. https://doi.org/10.1208/s12249-010-9486-9
Ammar HO, Salama H, Ghorab M, Mahmoud AA. Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. AAPS PharmSciTech. 2009;10:808–819. https://doi.org/10.1208/s12249-009-9268-4
Araújo FA, Kelmann RG, Araújo BV, Finatto RB, Teixeira HF, Koester LS. Development and characterization of parenteral nanoemulsions containing thalidomide. Eur J Pharm Sci. 2011;42(3):238–245. https://doi.org/10.1016/j.ejps.2010.11.014
Azeem A, Talegaonkar S, Negi LM, Ahmad FJ, Khar RK, Iqbal Z. Oil based nanocarrier system for transdermal delivery of ropinirole: a mechanistic, pharmacokinetic and biochemical investigation. Int J Pharm. 2012;422(1-2):436–444. https://doi.org/10.1016/j.ijpharm.2011.10.039
Laouini A, Andrieu V, Vecellio L, Fessi H, Charcosset C. Characterization of different vitamin E carriers intended for pulmonary drug delivery. Int J Pharm. 2014;471(1-2):385–390. https://doi.org/10.1016/j.ijpharm.2014.05.062
Okaru AO, Abuga KO, Kamau FN, Ndwigah SN, Lachenmeier DW. A robust liquid chromatographic method for confirmation of drug stability of Azithromycin in bulk samples, tablets and suspensions. Pharmaceutics. 2017;9(1):e11. https://doi.org/10.3390/pharmaceutics9010011
Chaudhari PM, Kuchekar MA. Development and evaluation of nanoemulsion as a carrier for topical delivery system by box-behnken design. Asian J Pharm Clin Res. 2018;11(8):286–293. http://dx.doi.org/10.22159/ajpcr.2018.v11i8.26359
Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm. 2007;329(1-2):166–172. https://doi.org/10.1016/j.ijpharm.2006.08.038
Ruan J, Liu J, Zhu D, et al. Preparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug–phospholipid complex technique. Int J Pharm. 2010;386(1-2):282–290. https://doi.org/10.1016/j.ijpharm.2009.11.026
Prajapati ST, Joshi HA, Patel CN. Preparation and characterization of self-microemulsifying drug delivery system of olmesartan medoxomil for bioavailability improvement. J Pharm. 2013;2013:e728425. https://doi.org/10.1155/2013/728425
Kulkarni M, Goge N, Date AA. Development of nanoemulsion preconcentrate of capsanthin with improved chemical stability. Assay Drug Dev Technol. 2020;18(1):34–44. https://doi.org/10.1089/adt.2019.916
Ismail A, Nasr M, Sammour O. Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: Improved pharmacokinetic/pharmacodynamic properties. Int J Pharm. 2020;583:e119402. https://doi.org/10.1016/j.ijpharm.2020.119402
Ebenazer A, Franklyne JS, Mukherjee A, Chandrasekaran N. Development of azithromycin loaded lemongrass oil based microemulsion and determination of antibacterial potential. Int J App Pharm. 2018;10(6):72–81. http://dx.doi.org/10.22159/ijap.2018v10i6.25417
Dasgupta S, Dey S, Choudhury S, Mazumder B. Topical delivery of aceclofenac as nanoemulsion comprising excipients having optimum emulsification capabilities: preparation, characterization and in vivo evaluation. Expert Opin Drug Deliv. 2013;10(4):411–420. https://doi.org/10.1517/17425247.2013.749234
Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. Design and development of oral oil in water ramipril nanoemulsion formulation: in vitro and in vivo assessment. J Biomed Nanotechnol. 2007;3(1):28–44. https://doi.org/10.1166/jbn.2007.008
Gurpreet K, Singh SK. Review of nanoemulsion formulation and characterization techniques. Indian J Pharm Sci. 2018;80(5):781–789.
Doost AS, Dewettinck K, Devlieghere F, Van der Meeren P. Influence of non-ionic emulsifier type on the stability of cinnamaldehyde nanoemulsions: a comparison of polysorbate 80 and hydrophobically modified inulin. Food Chem. 2018;258:237–244. https://doi.org/10.1016/j.foodchem.2018.03.078
Pund S, Thakur R, More U, Joshi A. Lipid based nanoemulsifying resveratrol for improved physicochemical characteristics, in vitro cytotoxicity and in vivo antiangiogenic efficacy. Colloids Surf B Biointerfaces 2014;120:110–117. https://doi.org/10.1016/j.colsurfb.2014.05.016
Asmawi AA, Salim N, Abdulmalek E, Rahman MBA. Modeling the effect of composition on formation of aerosolized nanoemulsion system encapsulating docetaxel and curcumin using D-Optimal mixture experimental design. Int J Mol Sci. 2020;21(12):e4357. https://doi.org/10.3390/ijms21124357
Adamski P, Dylik-Gromiec A. A determination of the cholesteric liquid crystalline temperature range by birefringence measurements in an Abbe refractometer. Mol Cryst Liq Cryst. 1974;25(3-4):273–280. https://doi.org/10.1080/15421407408082806
Patel RP, Joshi JR. An overview on nanoemulsion: a novel approach. Int J Pharm Sci Res. 2012;3(12):4640–4650.
Bhatt P, Madhav S. A detailed review on nanoemulsion drug delivery system. Int J Pharm Sci Res. 2011;2(10):2482–2489.
Barzegar H, Mehrnia MA, Nasehi B, Alipour M. Fabrication of peppermint essential oil nanoemulsions by spontaneous method: effect of preparing conditions on droplet size. Flavour Fragr J. 2018;33(5):351–356. https://doi.org/10.1002/ffj.3455
Asmawi AA, Salim N, Abdulmalek E, Rahman MBA. Size-controlled preparation of docetaxel-and curcumin-loaded nanoemulsions for potential pulmonary delivery. Pharmaceutics. 2023;15(2):e652. https://doi.org/10.3390/pharmaceutics15020652
Arbain NH, Salim N, Masoumi HRF, Wong TW, Basri M, Rahman MBA. In vitro evaluation of the inhalable quercetin loaded nanoemulsion for pulmonary delivery. Drug Deliv Transl Res. 2019;9:497–507. https://doi.org/10.1007/s13346-018-0509-5
Kalyoncu F, Cetin B, Saglam H. Antimicrobial activity of common madder (Rubia tinctorum L.). Phytother Res. 2006;20(6):490–492. https://doi.org/10.1002/ptr.1884
Azeem A, Rizwan M, Ahmad FJ, et al. Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech. 2009;10:69–76. https://doi.org/10.1208/s12249-008-9178-x
Nasr A, Gardouh A, Ghorab M. Novel solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of olmesartan medoxomil: design, formulation, pharmacokinetic and bioavailability evaluation. Pharmaceutics. 2016;8(3):e20. https://doi.org/10.3390/pharmaceutics8030020
Badawy MEI, Saad A-FS, Tayeb E-SHM, Mohammed SA, Abd-Elnabi AD. Optimization and characterization of the formation of oil-in-water diazinon nanoemulsions: modeling and influence of the oil phase, surfactant and sonication. J Environ Sci Health B. 2017;52(12):896–911. https://doi.org/10.1080/03601234.2017.1362941
Sugumar S, Mukherjee A, Chandrasekaran N. Eucalyptus oil nanoemulsion-impregnated chitosan film: Antibacterial effects against a clinical pathogen, Staphylococcus aureus, in vitro. Int J Nanomed. 2015;10(Suppl 2):67–75. https://doi.org/10.2147/IJN.S79982
Law S. Stability of preservative-free tobramycin in half-normal saline. Can J Hosp Pharm. 2001;54(3):214–215. https://doi.org/10.4212/cjhp.v54i3.659
Shah K, Chan LW, Wong TW. Critical physicochemical and biological attributes of nanoemulsions for pulmonary delivery of rifampicin by nebulization technique in tuberculosis treatment. Drug Deliv. 2017;24(1):1631–1647. https://doi.org/10.1080/10717544.2017.1384298
Bali V, Ali M, Ali J. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf B Biointerfaces. 2010;76(2):410–420. https://doi.org/10.1016/j.colsurfb.2009.11.021
Fyfe C, Grossman TH, Kerstein K, Sutcliffe J. Resistance to macrolide antibiotics in public health pathogens. Cold Spring Harb Perspect Med. 2016;6:a025395. https://doi.org/10.1101/cshperspect.a025395
Ashurst JV, Dawson A. Klebsiella Pneumonia. Treasure Island (FL), StatPearls Publishing; 2025
Braun HG, Perera SR, Tremblay YDN, Thomassin J.-L. Antimicrobial resistance in Klebsiella pneumoniae: an overview of common mechanisms and a current Canadian perspective. Can J Microbiol. 2024;70(12):507–528. https://doi.org/10.1139/cjm-2024-0032
Rocker A, Lacey JA, Belousoff MJ, et al. Global trends in proteome remodeling of the outer membrane modulate antimicrobial permeability in Klebsiella pneumoniae. mBio. 2020;11(2):e00603-20. https://doi.org/10.1128/mbio.00603-20
Copyright (c) 2025 Bisma Kiran, Qazi Amir Ijaz, Nasir Abbas, Amjad Hussain, Nadeem Irfan Bukhari
This work is licensed under a Creative Commons Attribution 4.0 International License.
Author(s) retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
